These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 27312863)

  • 21. Pharmacological topics of bone metabolism: the physiological function of the sympathetic nervous system in modulating bone resorption.
    Togari A; Arai M
    J Pharmacol Sci; 2008 Apr; 106(4):542-6. PubMed ID: 18431037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethnic and gender differences in bone mineral density and bone turnover in young adults: effect of bone size.
    Henry YM; Eastell R
    Osteoporos Int; 2000; 11(6):512-7. PubMed ID: 10982167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The osteoclast, bone remodelling and treatment of metabolic bone disease.
    Boyce BF; Rosenberg E; de Papp AE; Duong LT
    Eur J Clin Invest; 2012 Dec; 42(12):1332-41. PubMed ID: 22998735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical markers of bone turnover. A look at laboratory tests that reflect bone status.
    Rosen CJ; Tenenhouse A
    Postgrad Med; 1998 Oct; 104(4):101-2, 107-10, 113-4. PubMed ID: 9793558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease.
    Bartram SA; Peaston RT; Rawlings DJ; Walshaw D; Francis RM; Thompson NP
    World J Gastroenterol; 2006 Sep; 12(35):5680-6. PubMed ID: 17007022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteoporosis after spinal cord injury: aetiology, effects and therapeutic approaches.
    Abdelrahman S; Ireland A; Winter EM; Purcell M; Coupaud S
    J Musculoskelet Neuronal Interact; 2021 Mar; 21(1):26-50. PubMed ID: 33657753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone quality: what is it and how is it measured?
    Compston J
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):579-85. PubMed ID: 17117283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis of osteoporosis: concepts, conflicts, and prospects.
    Raisz LG
    J Clin Invest; 2005 Dec; 115(12):3318-25. PubMed ID: 16322775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of cortical bone in bone fragility.
    Bala Y; Zebaze R; Seeman E
    Curr Opin Rheumatol; 2015 Jul; 27(4):406-13. PubMed ID: 26002033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis of osteoporosis.
    Väänänen HK
    Calcif Tissue Int; 1991; 49 Suppl():S11-4. PubMed ID: 1933589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An association between abnormal bone turnover, systemic inflammation, and osteoporosis in patients with chronic pancreatitis: a case-matched study.
    Duggan SN; Purcell C; Kilbane M; O'Keane M; McKenna M; Gaffney P; Ridgway PF; Boran G; Conlon KC
    Am J Gastroenterol; 2015 Feb; 110(2):336-45. PubMed ID: 25623657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probiotics (Bifidobacterium longum) Increase Bone Mass Density and Upregulate Sparc and Bmp-2 Genes in Rats with Bone Loss Resulting from Ovariectomy.
    Parvaneh K; Ebrahimi M; Sabran MR; Karimi G; Hwei AN; Abdul-Majeed S; Ahmad Z; Ibrahim Z; Jamaluddin R
    Biomed Res Int; 2015; 2015():897639. PubMed ID: 26366421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteopenia and osteoporosis in children.
    Cassidy JT
    Clin Exp Rheumatol; 1999; 17(2):245-50. PubMed ID: 10342055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bone turnover in children and adolescents with diabetes mellitus type 1].
    Pater A; Odrowąż-Sypniewska G
    Pediatr Endocrinol Diabetes Metab; 2013; 19(2):78-81. PubMed ID: 25612640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [On "2015 Guidelines for Prevention and Treatment of Osteoporosis". The mechanism of bone fragility].
    Saito M
    Clin Calcium; 2015 Sep; 25(9):1301-6. PubMed ID: 26320529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P
    APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone Disease in Connective Tissue Disease/Systemic Lupus Erythematosus.
    Bultink IEM
    Calcif Tissue Int; 2018 May; 102(5):575-591. PubMed ID: 28900675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of bone turnover markers in the management of osteoporosis.
    Jain S; Camacho P
    Curr Opin Endocrinol Diabetes Obes; 2018 Dec; 25(6):366-372. PubMed ID: 30299435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Secondary osteoporosis or secondary contributors to bone loss in fracture. The relevance of immune system to bone metabolism].
    Tanaka Y
    Clin Calcium; 2013 Sep; 23(9):1265-70. PubMed ID: 23999361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The relationship between osteoporosis, osteopenia and periodontitis].
    Tayeb Y; Goultschin J; Fogel M; Schwartz Z
    Refuat Hapeh Vehashinayim (1993); 2003 Jan; 20(1):8-22, 78. PubMed ID: 12674920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.